Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Solubilizers
Topical
Emulsifying Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Levalbuterol Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levalbuterol Tartrate, including repackagers and relabelers. The FDA regulates Levalbuterol Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levalbuterol Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levalbuterol Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levalbuterol Tartrate supplier is an individual or a company that provides Levalbuterol Tartrate active pharmaceutical ingredient (API) or Levalbuterol Tartrate finished formulations upon request. The Levalbuterol Tartrate suppliers may include Levalbuterol Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Levalbuterol Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levalbuterol Tartrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Levalbuterol Tartrate active pharmaceutical ingredient (API) in detail. Different forms of Levalbuterol Tartrate DMFs exist exist since differing nations have different regulations, such as Levalbuterol Tartrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levalbuterol Tartrate DMF submitted to regulatory agencies in the US is known as a USDMF. Levalbuterol Tartrate USDMF includes data on Levalbuterol Tartrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levalbuterol Tartrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levalbuterol Tartrate suppliers with USDMF on PharmaCompass.
A Levalbuterol Tartrate written confirmation (Levalbuterol Tartrate WC) is an official document issued by a regulatory agency to a Levalbuterol Tartrate manufacturer, verifying that the manufacturing facility of a Levalbuterol Tartrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levalbuterol Tartrate APIs or Levalbuterol Tartrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Levalbuterol Tartrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Levalbuterol Tartrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levalbuterol Tartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levalbuterol Tartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levalbuterol Tartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levalbuterol Tartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levalbuterol Tartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levalbuterol Tartrate suppliers with NDC on PharmaCompass.
Levalbuterol Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levalbuterol Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levalbuterol Tartrate GMP manufacturer or Levalbuterol Tartrate GMP API supplier for your needs.
A Levalbuterol Tartrate CoA (Certificate of Analysis) is a formal document that attests to Levalbuterol Tartrate's compliance with Levalbuterol Tartrate specifications and serves as a tool for batch-level quality control.
Levalbuterol Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Levalbuterol Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levalbuterol Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Levalbuterol Tartrate EP), Levalbuterol Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levalbuterol Tartrate USP).
LOOKING FOR A SUPPLIER?
